private financing
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.
PreciseDx Raises $10.75M in Series A Round
The company is developing a cancer risk stratification technology that combines tissue-derived morphology information with clinical data.
MeMed Closes $93M Private Financing Round
The company said it will use the funds to scale manufacturing and accelerate commercialization of its MeMed BV and MeMed COVID-19 Severity tests.
Nucleix Raises Additional $22M
The Israeli molecular diagnostics firm is developing liquid biopsy tests for early-stage and recurring cancer detection based on methylation patterns.
Blood Collection Firm Tasso Closes $100M Series B Round
The Seattle-based company said it would use the funds to scale manufacturing and operations of its blood collection devices and health testing services.
Nov 16, 2021
PathologyWatch Completes $25M Series B Round
Aug 25, 2021
Recuro Health Raises $15M in Series A Round
Aug 5, 2021
Berry Oncology Raises $99.2M in Series B1 Round
Jul 13, 2021